Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

INTRODUCTION: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer (MBC), with overall survival benefits. OBJECTIVE: We evaluated the efficacy of dual HER-2 blockade combined with chemotherapy for HER-2-posit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Care (Basel)
Main Authors: Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923938/
https://ncbi.nlm.nih.gov/pubmed/33716633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506824
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados